TERT and neoplasm: Mutation of genetic loci within the Telomerase Reverse Transcriptase (TERT) promotor segment is observed in 6% of meningiomas, but this mutation occurs almost exclusively with concurrent chromosome 22q alterations, and the addition of a TERT promotor mutation is predictive of increased tumor aggressiveness and likelihood of recurrence.